NRC HEALTH (NRC)
D
Pipeline Grade
Financial Position (from SEC Filings)
$2.6M
Cash & Equivalents
$7.2M
Quarterly Burn Rate
$488M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-11-01 | Phase2 Readout | — |
| 2027-04-01 | Phase2 Readout | — |
| 2027-06-28 | Phase3 Readout | — |
Active Clinical Trials (14)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT06020677 | Latinx Children and Surgery | OTHER | Recruiting | 120 |
| NCT06747871 | Opioids, Low Nicotine Cigarettes, and Chronic Pain | OTHER | Recruiting | 60 |
| NCT06791122 | A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patien... | OTHER | Active Not Recruiting | 262 |
| NCT07211035 | Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1) | OTHER | Recruiting | 160 |
| NCT02993523 | A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Mye... | PHASE3 | Active Not Recruiting | 443 |
| NCT07140913 | A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur... | PHASE3 | Recruiting | 424 |
| NCT05304767 | An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Control... | PHASE3 | Recruiting | 280 |
| NCT06929273 | A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3) | PHASE3 | Recruiting | 450 |
| NCT05616650 | Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor | PHASE2 | Recruiting | 42 |
| NCT07108309 | BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer | PHASE2 | Recruiting | 124 |
| NCT07220460 | Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipol... | PHASE2 | Recruiting | 200 |
| NCT06846320 | Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in... | PHASE2 | Recruiting | 315 |
| NCT06465420 | A Study to Evaluate Safety and Immunogenicity of Haemophilus Influenzae Serotype A Vaccine | PHASE1 | Active Not Recruiting | 30 |
| NCT07543744 | A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastati... | PHASE1 | Recruiting | 180 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.